EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
Author:
Publication date:
2021
Publisher version:
Citación:
Annals of the Rheumatic Diseases, 80(6), p. 698-706 (2021); doi:10.1136/annrheumdis-2020-219724
Descripción física:
p. 698-706
ISSN:
Patrocinado por:
This work was funded by European League Against Rheumatism (CLI122). PMM is supported by the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC). JDI is a NIHR Senior Investigator and his work is supported by the NIHR Newcastle Biomedical Research Centre in Ageing and Long- Term Conditions, and the Research Into Inflammatory Arthritis Centre versus Arthritis. AVR is a member of the paediatric steering committee of RECOVERY, the steering committee of COVINTOC study and the steering committee of baricitinib in COVID-19.
Collections
- Artículos [36141]
- Biología Funcional [754]
Files in this item
Métricas
Compartir
Estadísticas de uso
Metadata
This item is protected with a Creative Commons License